2 Followers on Owler

Euthymics

Euthymics Bioscience is a neuroscience-focused biopharmaceutical company that develops medicines for depressive disorders. Read more

Anthony McKinney's photo - Co-Founder & CEO of Euthymics

Co-Founder & CEO

Anthony McKinney

CEO Approval Rating

71/100

Founded:

2009

Status:

PrivateIndependent Company

Est. Annual Revenue
Est. Employees
Sector

Update Industry

EUTHYMICS TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Ocular Therapeutix is seen as one of Euthymics's top competitors. Ocular Therapeutix was founded in Bedford, Massachusetts} in 2006. Ocular Therapeutix is in the Pharmaceuticals industry. Compared to Euthymics, Ocular Therapeutix generates $16.4M more revenue.

Mati Therapeutics is Euthymics's #2 competitor. Mati Therapeutics was founded in 2012, and its headquarters is in Austin, Texas. Mati Therapeutics is in the Pharmaceuticals field. Mati Therapeutics has 21 fewer employees than Euthymics.

Ora is Euthymics's #3 rival. Ora is headquartered in Andover, Massachusetts, and was founded in 1977. Ora operates in the Pharmaceuticals industry. Ora generates 175% the revenue of Euthymics.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Aerpio a competitor of Euthymics?

Euthymics Acquisitions

No recent acquisitions found related to Euthymics

Euthymics Funding History

Since Euthymics was founded in 2009, it has participated in 4 rounds of funding. In total Euthymics has raised $58.3M. Euthymics' last funding round was on May 2017 for a total of $300.0K

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
May 2017
$300K
-
Debt
Feb 2016
$7.5M
-
Equity
Oct 2012
$26.5M
Series A
Jul 2010
$24M

Since Euthymics was founded in 2009, it has participated in 4 rounds of funding. In total Euthymics has raised $58.3M. Euthymics' last funding round was on May 2017 for a total of $300.0K

Euthymics Investments

No recent investments found related to Euthymics

Euthymics News

Euthymics Press Releases

Social Media

Euthymics Headquarters

43 Thorndike St Suite S1-3

Cambridge, Massachusetts02141

617-758-0300

Driving Directions »

Trending Companies

Euthymics Summary

ABOUT

Overview

Euthymics Bioscience is a neuroscience-focused biopharmaceutical company that develops medicines for depressive disorders. Euthymics was founded in 2009. Euthymics' headquarters is located in Cambridge, Massachusetts, USA 02141. It has raised 58.3M in...

CEO

Euthymics's Co-Founder & CEO, Anthony McKinney, currently has an approval rating of 71%. Euthymics's primary competitors are Ocular Therapeutix, Mati Therapeutics & Ora.

Frequently Asked Questions about Euthymics

  1. When was Euthymics founded?

    Euthymics was founded in 2009
  2. Who is Euthymics's CEO?

    Euthymics's CEO is Anthony McKinney
  3. How much revenue does Euthymics generate?

    Euthymics generates $5.7M in revenue
  4. How much funding does Euthymics have?

    Euthymics has historically raised $58.3M in funding
  1. Where is Euthymics's headquarters?

    Euthymics's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Euthymics have?

    Euthymics has 48 employees
  3. Who are Euthymics's competitors?

    Euthymics's top competitors are Ocular Therapeutix, Mati Therapeutics, Ora